Literature DB >> 35582358

Immunoexpression of CXCL12 and CXCR4 in sporadic and Gorlin-Goltz syndrome-related odontogenic keratocysts.

Wliana-Pontes de Lima1, Allany-de Oliveira Andrade1, Roberta-Barroso Cavalcante2, Renato-Luiz-Maia Nogueira3, Pollianna-Muniz Alves1, Cassiano-Francisco-Weege Nonaka1, Manuel-Antonio Gordón-Núñez1.   

Abstract

Background: Differences in the pathogenesis and biological behavior of sporadic and Gorlin-Goltz syndrome-related odontogenic keratocysts (OKCs) have been reported, but the underlying mechanisms are not fully elucidated. Chemokine CXCL12 and its main receptor CXCR4 regulate important events in the pathogenesis of several lesions. Material and
Methods: This study evaluated the immunoexpression of CXCL12 and CXCR4 in sporadic and syndromic OKCs. Twenty-two sporadic OKCs and 22 syndromic OKCs were subjected to immunohistochemistry. The percentages of cytoplasmic (CXCL12 and CXCR4) and nuclear (CXCR4) staining in epithelial and fibrous capsule cells were determined. The results were analyzed statistically using the nonparametric Mann-Whitney test and Spearman correlation test (p<0.05).
Results: Higher cytoplasmic expression of CXCL12 was observed in the epithelial lining and fibrous capsule of sporadic OKCs compared to syndromic OKCs (p<0.001). No statistically significant differences in the cytoplasmic expression of CXCR4 were observed between syndromic OKCs and sporadic OKCs (p>0.05). Compared to syndromic OKCs, sporadic OKCs exhibited higher nuclear expression of CXCR4 in the epithelial lining and lower immunoexpression in the fibrous capsule (p<0.05). In the epithelial lining of syndromic OKCs, positive correlation was observed between cytoplasmic and nuclear expressions of CXCR4 (p=0.003). In the fibrous capsule of syndromic OKCs and sporadic OKCs, cytoplasmic and nuclear expressions of CXCR4 were positively correlated (p<0.001). Conclusions: The results suggest a potential participation of CXCL12 and CXCR4 in the development of OKCs. The heterogeneous expression of these proteins in syndromic and sporadic OKCs may reflect differences in their pathogenesis and biological behavior. Key words:Odontogenic keratocyst, CXCL12, CXCR4, Immunohistochemistry. Copyright:
© 2022 Medicina Oral S.L.

Entities:  

Year:  2022        PMID: 35582358      PMCID: PMC9094726          DOI: 10.4317/jced.59561

Source DB:  PubMed          Journal:  J Clin Exp Dent        ISSN: 1989-5488


  5 in total

1.  CXCL12 activation of CXCR4 regulates mucosal host defense through stimulation of epithelial cell migration and promotion of intestinal barrier integrity.

Authors:  Jennifer M Smith; Priscilla A Johanesen; Michael K Wendt; David G Binion; Michael B Dwinell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-09-09       Impact factor: 4.052

2.  A Brazilian multicentre study of 2,497 isolated cases of odontogenic keratocysts.

Authors:  Lauren Frenzel Schuch; José Alcides Almeida de Arruda; Carla Mosconi; Laura Borges Kirschnick; Rodrigo Finger de Carvalho Pinho; Stephanie Kenig Viveiros; Lucas Guimarães Abreu; Gleyson Kleber do Amaral-Silva; Leorik Pereira da Silva; Roberta Rayra Martins-Chaves; Ana Carolina Uchoa Vasconcelos; Ana Paula Neutzling Gomes; Elena Riet Correa Rivero; Manoela Domingues Martins; Pantelis Varvaki Rados; Oslei Paes de Almeida; Bruno Augusto Benevenuto de Andrade; Mário José Romañach; Michelle Agostini; Elismauro Francisco de Mendonça; Hélder Antonio Rebelo Pontes; Lélia Batista de Souza; Felipe Paiva Fonseca; Maria Cássia Ferreira de Aguiar; Suzana Cantanhede Orsini Machado de Sousa; Ricardo Alves Mesquita
Journal:  Oral Dis       Date:  2020-01-09       Impact factor: 3.511

3.  Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts.

Authors:  Cassiano Francisco Weege Nonaka; Roberta Barroso Cavalcante; Renato Luiz Maia Nogueira; Lélia Batista de Souza; Leão Pereira Pinto
Journal:  Arch Oral Biol       Date:  2011-08-25       Impact factor: 2.633

4.  Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.

Authors:  Agnieszka Jaracz-Ros; Guillaume Bernadat; Pasquale Cutolo; Carmen Gallego; Martin Gustavsson; Erika Cecon; Françoise Baleux; Irina Kufareva; Tracy M Handel; Françoise Bachelerie; Angélique Levoye
Journal:  J Leukoc Biol       Date:  2020-05-06       Impact factor: 4.962

Review 5.  New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours.

Authors:  Paul M Speight; Takashi Takata
Journal:  Virchows Arch       Date:  2017-07-03       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.